Article info
Original Article
Prognostic significance of PD-1 and PD-L1 positive tumor-infiltrating immune cells in ovarian carcinoma
- Correspondence to Dr Paul Buderath, Department of Gynecology, University Hospital Essen, Essen 45147, Germany; paul.buderath{at}uk-essen.de
Citation
Prognostic significance of PD-1 and PD-L1 positive tumor-infiltrating immune cells in ovarian carcinoma
Publication history
- Received May 13, 2019
- Revision received July 25, 2019
- Accepted July 30, 2019
- First published September 5, 2019.
Article Versions
- You are currently viewing a Previous version of this article (3 November 2019).
- View the most recent version of this article
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2019. No commercial re-use. See rights and permissions. Published by BMJ.